116 related articles for article (PubMed ID: 11031741)
1. [Pharmacology of the glutamate receptor].
Shinozaki H
Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):125-31. PubMed ID: 11031741
[TBL] [Abstract][Full Text] [Related]
2. Potentiation by DL-alpha-aminopimelate of the inhibitory action of a novel mGluR agonist (L-F2CCG-I) on monosynaptic excitation in the rat spinal cord.
Saitoh T; Ishida M; Shinozaki H
Br J Pharmacol; 1998 Feb; 123(4):771-9. PubMed ID: 9517398
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of uptake and release of a novel mGluR agonist (L-F2CCG-I) by anion transport blockers in the rat spinal cord.
Ishida M; Shinozaki H
Neuropharmacology; 1999 Oct; 38(10):1531-41. PubMed ID: 10530815
[TBL] [Abstract][Full Text] [Related]
4. Selective metabotropic receptor agonists distinguish non-ionotropic glutamate binding sites.
Testa CM; Hollingsworth ZR; Shinozaki H; Penney JB; Young AB
Brain Res; 1997 Oct; 773(1-2):15-27. PubMed ID: 9409700
[TBL] [Abstract][Full Text] [Related]
5. A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.
Ishida M; Saitoh T; Shimamoto K; Ohfune Y; Shinozaki H
Br J Pharmacol; 1993 Aug; 109(4):1169-77. PubMed ID: 8401927
[TBL] [Abstract][Full Text] [Related]
6. Excitatory amino acids: physiological and pharmacological probes for neuroscience research.
Shinozaki H; Ishida M
Acta Neurobiol Exp (Wars); 1993; 53(1):43-51. PubMed ID: 8317271
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacology of excitatory amino acid receptors].
Shinozaki H
Yakubutsu Seishin Kodo; 1992 Apr; 12(2):55-65. PubMed ID: 1359719
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat.
Miyamoto M; Ishida M; Shinozaki H
Neuroscience; 1997 Mar; 77(1):131-40. PubMed ID: 9044381
[TBL] [Abstract][Full Text] [Related]
9. Neuron damage induced by some potent kainoids and neuroprotective action of new agonists for metabotropic glutamate receptors.
Shinozaki H
Eur Neurol; 1994; 34 Suppl 3():2-9. PubMed ID: 7821331
[TBL] [Abstract][Full Text] [Related]
10. Changes in preference for receptor subtypes of configurational variants of a glutamate analog: conversion from the NMDA-type to the non-NMDA type.
Ishida M; Ohfune Y; Shimada Y; Shimamoto K; Shinozaki H
Brain Res; 1991 May; 550(1):152-6. PubMed ID: 1653635
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the metabotropic glutamate receptor inhibiting D-[3H]-aspartate output in rat striatum.
Lombardi G; Alesiani M; Leonardi P; Cherici G; Pellicciari R; Moroni F
Br J Pharmacol; 1993 Dec; 110(4):1407-12. PubMed ID: 8306080
[TBL] [Abstract][Full Text] [Related]
12. L-CCG-I activates group III metabotropic glutamate receptors in the hippocampal CA3 region.
Kirschstein T; von der Brelie C; Steinhäuser M; Vinçon A; Beck H; Dietrich D
Neuropharmacology; 2004 Aug; 47(2):157-62. PubMed ID: 15223294
[TBL] [Abstract][Full Text] [Related]
13. A marked increase in intracellular Ca2+ concentration induced by acromelic acid in cultured rat spinal neurons.
Ogata T; Nakamura Y; Tsuji K; Shibata T; Kataoka K; Ishida M; Shinozaki H
Neuropharmacology; 1994 Sep; 33(9):1079-85. PubMed ID: 7838320
[TBL] [Abstract][Full Text] [Related]
14. Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain.
Shave E; Pliss L; Lawrance ML; FitzGibbon T; Stastny F; Balcar VJ
Neurochem Int; 2001 Jan; 38(1):53-62. PubMed ID: 10913688
[TBL] [Abstract][Full Text] [Related]
15. The activation of glutamate receptors by kainic acid and domoic acid.
Hampson DR; Manalo JL
Nat Toxins; 1998; 6(3-4):153-8. PubMed ID: 10223631
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat.
Pizzi M; Benarese M; Boroni F; Goffi F; Valerio A; Spano PF
Neuropharmacology; 2000 Mar; 39(5):903-10. PubMed ID: 10699456
[TBL] [Abstract][Full Text] [Related]
17. Glutamate receptor agonists modulate [Ca2+]i in isolated rat melanotropes.
Giovannucci DR; Stuenkel EL
Neuroendocrinology; 1995 Aug; 62(2):111-22. PubMed ID: 8584110
[TBL] [Abstract][Full Text] [Related]
18. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.
Abraham KE; McGinty JF; Brewer KL
Neuroscience; 2001; 104(3):863-74. PubMed ID: 11440816
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes.
Nishi N; Odagaki Y; Koyama T
Br J Pharmacol; 2000 Aug; 130(7):1664-70. PubMed ID: 10928972
[TBL] [Abstract][Full Text] [Related]
20. Effects of metabotropic glutamate receptor agonists and antagonists on D-aspartate release from mouse cerebral cortical and striatal slices.
Janáky R; Dohovics R; Hermann A; Oja SS; Saransaari P
Neurochem Res; 2001 Nov; 26(11):1217-24. PubMed ID: 11874203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
